Pharmaceutical Intermediate API Body Building CAS 148031 -34-9 99% Powder Pure Peptide Eptifibatide Acetate

China Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate, Find details about China CAS 148031-34-9, Eptifibatide from Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate

Model NO.
EPT
Trademark
Greenway
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Origin
Jiangsu, China
HS Code
2942000000
Model NO.
EPT
Trademark
Greenway
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Origin
Jiangsu, China
HS Code
2942000000

Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate

Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Product Description of Pharmaceutical Grade Intermediates  Ingredient Nootropic Powder CAS 314728-85-3 Bulk 99% Adrafinil/Piperazine, 1-Benzoyl-4-(1-Oxopropyl)-/Sunifiram
{Product Name}:Eptifibatide
{Other Name}:Eptifibatide Acetate
{Test Method.}: HPLC
{Appearance}: White Powder
{Specification}:99%
{MOQ}: 1kg

SEptifibatide is a glycoprotein (GP) IIb/IIIa receptor (platelet coagulation factor I receptor) antagonist. Through the final common pathway of selective and reversible inhibition of platelet aggregation (plasma coagulation due to the combination of coagulation factor and GPb/a), the ischemic state caused by thrombosis can be reversed.

Function of Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
1. Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e. G., non-Q-wave) myocardial infarction (i. E., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronaryintervention (PCI).
2. Treat the adults and the children above6 years old chronic humanity flaw virus(HIV)infects. Chronic humanity flaw virus(HIV)infects.


Application of Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Used for acute coronary syndrome and percutaneous coronary intervention.

Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide AcetatePharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate


Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate
Pharmaceutical Intermediate API Body Building CAS 148031-34-9 99% Powder Pure Peptide Eptifibatide Acetate

Send us an inquiry